FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1856961639> ?p ?o ?g. }

• W1856961639 endingPage "2781" @default.
• W1856961639 startingPage "2781" @default.
• W1856961639 abstract "In osteosarcoma, prognostic factors at diagnosis other than clinical stage have not been clearly identified. The aim of this study was to determine whether human epidermal growth factor receptor 2 (HER2)/erbB-2, p-glycoprotein, or p53 expression correlated with histologic response to preoperative chemotherapy or event-free survival.We performed a retrospective immunohistochemical study on material obtained from patients treated on the Memorial Sloan-Kettering Cancer Center T12 protocol between 1986 and 1993. Paraffin-embedded tissue was identified from 53 patients (73% of patients enrolled onto protocol) and stained for HER2/erbB-2, p53, and p-glycoprotein expression using standard monoclonal antibodies and methods.At the time of initial biopsy, 20 (42.6%) of 47 samples demonstrated high levels of HER2/erbB-2 expression. Higher frequencies of expression were observed in samples from patients with metastatic disease at presentation and at the time of relapse. Expression of HER2/erbB-2 correlated with a significantly worse histologic response (P =.03). In patients presenting with nonmetastatic disease, expression of HER2/erbB-2 at the time of initial biopsy was associated with a significantly decreased event-free survival (47% v 79% at 5 years, P =.05). p53 and p-glycoprotein expression did not correlate with histologic response or patient event-free survival.The correlation of HER2/erbB-2 expression with histologic response to preoperative chemotherapy and event-free survival in this study suggests that HER2/erbB-2 should be evaluated prospectively as a prognostic indicator. The correlation also suggests that clinical trials of antibodies that target this receptor, such as recombinant humanized anti-HER2 monoclonal antibody (Herceptin; Genentech, San Francisco, CA), should be considered for the treatment of osteosarcoma." @default.
• W1856961639 created "2016-06-24" @default.
• W1856961639 creator A5010913859 @default.
• W1856961639 creator A5017081282 @default.
• W1856961639 creator A5022207361 @default.
• W1856961639 creator A5031035765 @default.
• W1856961639 creator A5032743242 @default.
• W1856961639 creator A5068981993 @default.
• W1856961639 creator A5084154593 @default.
• W1856961639 date "1999-09-01" @default.
• W1856961639 modified "2023-10-17" @default.
• W1856961639 title "Expression of HER2/<i>erb</i>B-2 Correlates With Survival in Osteosarcoma" @default.
• W1856961639 cites W1854116296 @default.
• W1856961639 cites W1857092002 @default.
• W1856961639 cites W1864208984 @default.
• W1856961639 cites W1902222293 @default.
• W1856961639 cites W1946181835 @default.
• W1856961639 cites W1954845453 @default.
• W1856961639 cites W1966823692 @default.
• W1856961639 cites W1967475886 @default.
• W1856961639 cites W1973913393 @default.
• W1856961639 cites W1992752045 @default.
• W1856961639 cites W2060688081 @default.
• W1856961639 cites W2063759313 @default.
• W1856961639 cites W2076249181 @default.
• W1856961639 cites W2091707087 @default.
• W1856961639 cites W2101577390 @default.
• W1856961639 cites W2110442763 @default.
• W1856961639 cites W2142136189 @default.
• W1856961639 cites W2154027407 @default.
• W1856961639 cites W2164449865 @default.
• W1856961639 cites W2169795422 @default.
• W1856961639 cites W2222638000 @default.
• W1856961639 cites W2264342946 @default.
• W1856961639 cites W2325060315 @default.
• W1856961639 cites W2329552021 @default.
• W1856961639 cites W2408062821 @default.
• W1856961639 cites W4245103890 @default.
• W1856961639 cites W4306658195 @default.
• W1856961639 doi "https://doi.org/10.1200/jco.1999.17.9.2781" @default.
• W1856961639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10561353" @default.
• W1856961639 hasPublicationYear "1999" @default.
• W1856961639 type Work @default.
• W1856961639 sameAs 1856961639 @default.
• W1856961639 citedByCount "296" @default.
• W1856961639 countsByYear W18569616392012 @default.
• W1856961639 countsByYear W18569616392013 @default.
• W1856961639 countsByYear W18569616392014 @default.
• W1856961639 countsByYear W18569616392015 @default.
• W1856961639 countsByYear W18569616392016 @default.
• W1856961639 countsByYear W18569616392017 @default.
• W1856961639 countsByYear W18569616392018 @default.
• W1856961639 countsByYear W18569616392019 @default.
• W1856961639 countsByYear W18569616392020 @default.
• W1856961639 countsByYear W18569616392021 @default.
• W1856961639 countsByYear W18569616392022 @default.
• W1856961639 countsByYear W18569616392023 @default.
• W1856961639 crossrefType "journal-article" @default.
• W1856961639 hasAuthorship W1856961639A5010913859 @default.
• W1856961639 hasAuthorship W1856961639A5017081282 @default.
• W1856961639 hasAuthorship W1856961639A5022207361 @default.
• W1856961639 hasAuthorship W1856961639A5031035765 @default.
• W1856961639 hasAuthorship W1856961639A5032743242 @default.
• W1856961639 hasAuthorship W1856961639A5068981993 @default.
• W1856961639 hasAuthorship W1856961639A5084154593 @default.
• W1856961639 hasConcept C121608353 @default.
• W1856961639 hasConcept C126322002 @default.
• W1856961639 hasConcept C142724271 @default.
• W1856961639 hasConcept C143998085 @default.
• W1856961639 hasConcept C146357865 @default.
• W1856961639 hasConcept C151730666 @default.
• W1856961639 hasConcept C204232928 @default.
• W1856961639 hasConcept C2775934546 @default.
• W1856961639 hasConcept C2776694085 @default.
• W1856961639 hasConcept C2777760704 @default.
• W1856961639 hasConcept C2779251935 @default.
• W1856961639 hasConcept C71924100 @default.
• W1856961639 hasConcept C86803240 @default.
• W1856961639 hasConceptScore W1856961639C121608353 @default.
• W1856961639 hasConceptScore W1856961639C126322002 @default.
• W1856961639 hasConceptScore W1856961639C142724271 @default.
• W1856961639 hasConceptScore W1856961639C143998085 @default.
• W1856961639 hasConceptScore W1856961639C146357865 @default.
• W1856961639 hasConceptScore W1856961639C151730666 @default.
• W1856961639 hasConceptScore W1856961639C204232928 @default.
• W1856961639 hasConceptScore W1856961639C2775934546 @default.
• W1856961639 hasConceptScore W1856961639C2776694085 @default.
• W1856961639 hasConceptScore W1856961639C2777760704 @default.
• W1856961639 hasConceptScore W1856961639C2779251935 @default.
• W1856961639 hasConceptScore W1856961639C71924100 @default.
• W1856961639 hasConceptScore W1856961639C86803240 @default.
• W1856961639 hasIssue "9" @default.
• W1856961639 hasLocation W18569616391 @default.
• W1856961639 hasLocation W18569616392 @default.
• W1856961639 hasOpenAccess W1856961639 @default.
• W1856961639 hasPrimaryLocation W18569616391 @default.
• W1856961639 hasRelatedWork W1129363153 @default.
• W1856961639 hasRelatedWork W2320346276 @default.

• next